TRACON Pharmaceuticals Inc

NASDAQ:TCON   3:59:53 PM EDT
1.80
+0.03 (+1.70%)
Other Pre-Announcement

TRACON Expects Current Cash And Cash Equivalents Will Fund Operations Into 2023

Published: 05/11/2022 20:58 GMT
TRACON Pharmaceuticals Inc (TCON) - Tracon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Tracon Pharmaceuticals Inc - Expects That Its Current Cash and Cash Equivalents Will Fund Operations Into 2023.
Tracon Pharmaceuticals Inc - Qtrly Loss per Share $0.48.